The goal of the Mission on Cancer is to improve the lives of more than 3 million people by 2030, through prevention, cure and for those affected by cancer including their families, to live longer and better
Published on | 1 year ago
Last updated on | 4 months ago
The goal of the Mission on Cancer is to improve the lives of more than 3 million people by 2030, through prevention, cure and for those affected by cancer including their families, to live longer and better.
Cancer affects everyone regardless of age, gender or social status and represents a tremendous burden for patients, families, and societies at large. If no further action is taken, the number of people newly diagnosed with cancer every year in Europe will increase from the current 3.5 million to more than 4.3 million by 2035. A mission in this area will help set common goals aiming to reverse these frightening trends in cancer.
By joining efforts across Europe, the Mission on Cancer together with the Europe’s Beating Cancer Plan will provide a better understanding of cancer, allow for earlier diagnosis and optimise treatment and improve cancer patients’ quality of life during and beyond their cancer treatment.
The Cancer Mission Implementation Plan aims to be the operational blueprint for how the Commission will deliver on the overall objective of the Mission on Cancer, providing an operational course of action across the four objectives. It specifies the main actions to be undertaken over the lifetime of the Mission, with an emphasis on the first three years (2021-2023).
The Commission invites researchers and innovators as well as citizens and all interested stakeholders to take part in the Mission on Cancer. Information on the Cancer Mission calls can be consulted on the Funding & Tenders Portal. Currently there are no open or forthcoming calls under the Cancer Mission.
A portfolio of projects & results (total EU-funding well over €3.5 billion) on cancer research and innovation funded under past framework programmes FP6 (2002-2006), FP7 (2007-2013) and Horizon 2020 (2014-2020) and the current Horizon Europe framework programme (2021-2027) can be found in the CORDIS database.
Cancer-related projects supported by European Regions can be found in the KOHESIO database.
The Commission has made its first assessment of the EU Missions in a Communication published in the 3rd quarter of 2023. It expresses the Commission’s support for the continuation of the 5 EU Missions. An external assessment of EU Missions was commissioned to underpin the Commission assessment, including a review of the Cancer Mission. You can find the summary of this review here & the full review is available here.
Find it out here.
We offer news and event updates, covering all domains and topics of Horizon 2020 & Horizon Europe.
Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 twinning project ScreenME has as its objective to enhance excellence in screen media entrepreneurship at Tallinn University (TLU). To do so, ScreenME has established a network of universities across Europe that aim to improve research into and teaching of entrepreneurship for the screen media industry. ScreenME will develop a teaching course and will kick off research initiatives and projects on entrepreneurial activities in media organisations. The research group on ‘Studies in Media, Innovation and Technology (SMIT)’ of the Vrije Universiteit Brussel (VUB) is partner in the network and is involved in two cross-cutting activities of the project: support for early stage researchers and developing stakeholder involvement.